• December 20, 2024

Humacyte stock surges over 50% on FDA approval

Investing.com -- Shares of Humacyte Inc. soared +56% in pre-open trading Friday following the announcement that the U.S. Food and Drug Administration (FDA) has granted full approval for its SYMVE...

0.131931s